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 Abstract 
 The cerebellum forms a highly ordered and indispensible component of motor function within 
the adult neuraxis, consisting of several distinct cellular subtypes. Cerebellar disease, through 
a variety of genetic and acquired causes, results in the loss of function of deﬁ ned subclasses of 
neurons, and remains a signiﬁ cant and untreatable health care burden. The scarcity of therapies 
in this arena can partially be explained by unresolved disease mechanisms due to inaccessibility 
of human cerebellar neurons in a relevant experimental context where initiating disease mecha-
nisms could be functionally elucidated, or drug screens conducted. In this review we discuss the 
potential promise of human induced pluripotent stem cells (hiPSCs) for regenerative neurology, 
with a particular emphasis on in vitro modelling of cerebellar degeneration. We discuss prog-
ress made thus far using hiPSC-based models of neurodegeneration, noting the relatively slower 
pace of discovery made in modelling cerebellar dysfunction. We conclude by speculating how 
strategies attempting cerebellar diﬀ erentiation from hiPSCs can be reﬁ ned to allow the genera-
tion of accurate disease models. This in turn will permit a greater understanding of cerebellar 
pathophysiology to inform mechanistically rationalised therapies, which are desperately needed 
in this ﬁ eld. 
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 Keywords 
 Cerebellum ,  directed diﬀ erentiation ,  disease 
modelling ,  iPSC-technology ,  reprogramming 
thalamus and pontine, medullary reticular, red and vestibular 
nuclei (De Zeeuw  & Berrebi, 1995; Ito, 1984; Voogd et  al., 
1996; Ruigrok, 2011). Using non-induced pluripotent stem cell 
(iPSC)-based approaches, the cerebellum has been extensively 
studied and has well-established functions in motor control and 
motor learning, (ﬁ ne) coordination, posture and balance (Ito, 
1984; Glickstein et  al., 2009; Schmahmann, 1997). Additionally, 
there is growing evidence implicating the cerebellum in cogni-
tive functions and emotion (Strata, 2015; Strick et  al., 2009; 
Anand et  al., 1959; Timmann, 2012). Its unique organisation, 
precise wiring and distinct pathophysiology make this particular 
structure equally vulnerable to injury and diﬃ  cult to repair. 
 Regenerative medicine has been revolutionised by the 
potential of disease modelling and manipulation via hiPSC 
technology, a recent discovery later recognised by the Nobel 
Prize in Physiology or Medicine (Takahashi et  al., 2007; Tabar 
 & Studer, 2014). Diﬀ erentiation of hiPSCs from healthy and 
diseased individuals into neuronal cells permits investigation 
and modelling of human neurodevelopmental processes. It 
also signiﬁ cantly fosters our understanding of the pathologi-
cal processes driving diﬀ erent developmental and degenera-
tive diseases and thus informs strategies to ameliorate disease 
progression, with the ultimate aim to restore structure and 
function (Xie  & Zhang, 2015). Speciﬁ c advantages include 
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 Introduction 
 The cerebellum, also termed  ‘ little brain ’ , is an extensively 
researched part of the neuraxis. Nonetheless, the molecular 
pathogenesis underlying cerebellar disease remains poorly 
understood, with the vast majority of such disorders still being 
immedicable to date (Manto, 2008). As one of the more principal 
neuraxial structures with high cellular and structural complexity, 
the cerebellum integrates and orchestrates  ∼ 80% of the number 
of total CNS neurons in only 10% of the total volume (Azevedo 
et  al., 2009). Its anatomical location in the posterior cranial 
fossa is functionally related to coordinating the major input from 
pontine and vestibular nuclei, the inferior olive and spinal cord 
to the cerebellum ’ s major output pathways via the ventrolateral 
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not only directed diﬀ erentiation of any human cell type to 
model disease in a highly reductionist fashion but also that 
these cells will express mutations at a normal pathophysi-
ological level, removing the need for artiﬁ cial overexpression, 
knockdown or knockout. Furthermore, given their theoretically 
limitless potential to proliferate before directed diﬀ erentiation 
into clinically relevant cell types, this  ‘ renewable ’ resource 
for experimental material both recapitulates disease pheno-
types and further enables high-throughput drug screening in 
search of a revertive therapeutic agent (Efthymiou et  al., 2014; 
Malik et  al., 2014; Yang et  al., 2013). A second more long-term 
promise of hiPSCs will be patient-targeted individual therapy 
through transplantation, although accurate restoration of circuit 
integrity and function after damage will be a formidable task. 
 The advent of hiPSCs is of particular relevance to a struc-
ture like the cerebellum both from developmental and clinical 
neurological perspectives as most of the mysteries remain to 
be unravelled (Manto, 2008; Leiner, 2010; Voogd, 2014) and 
no cure is available for the treatment of the vast majority of 
cerebellar diseases. Against this background, understanding 
the developmental  ‘ logic ’ of cerebellar diﬀ erentiation is es-
sential to ﬁ rst permit reproducible directed diﬀ erentiation of 
hiPSCs in vitro, in order to generate accurate disease models 
for a variety of cerebellar disorders. 
 Here we highlight the promise of iPSC technology to re-
generative medicine, and especially neurology with a speciﬁ c 
focus on the cerebellum. We ﬁ rst discuss the prospects and 
remaining challenges of iPSC technology before focussing 
speciﬁ cally on current strategies, achievements and limita-
tions for directed diﬀ erentiation to cerebellar neurons. We 
conclude by summarising the advances in modelling human 
cerebellar degeneration using hiPSCs and speculating on fu-
ture areas of interest at the experimental interface between 
cerebellar neurology and human stem cell-based disease 
modelling  ‘ in-a-dish ’ . 
 iPSC technology and its relevance to medicine 
 The discovery of eﬃ  cient reprogramming of adult human 
ﬁ broblasts into iPSCs in 2007 (Takahashi et  al., 2007) has 
since caused a fundamental paradigm shift in regenerative 
medicine. Subsequent technique optimisation and reﬁ nement 
of reproducibility and scalability (Okita et  al., 2011; Schlaeger 
et  al., 2015; Yu et  al., 2009; Jiang et  al., 2013; Hou et  al., 2013; 
Warren et  al., 2010) have only reinforced the importance of 
hiPSC-based modelling. With the help of a small number of 
transgenes it is becoming a standardised procedure to revert 
primary somatic cells of diseased patients and healthy con-
trol individuals into iPSCs for many laboratories worldwide, 
indeed this technology has also attracted considerable (and 
growing) commercial interest. These reprogramming methods 
somewhat circumvent ethical concerns accompanied by the 
use of primary human embryonic stem cells (hESCs) for medi-
cal research, and revolutionise predating approaches including 
somatic nuclear transfer into oocytes or fusion with ESCs, 
leading to tetraploidy (Yamanaka  & Blau, 2010). The theo-
retically endless capability of self-renewal and the preserved 
genetic background (where mutated genes are expressed at 
a representative pathophysiological level) render hiPSCs an 
unprecedented and unparalleled resource. Combined with 
ongoing advances in the ﬁ eld of directed diﬀ erentiation into 
disease-speciﬁ c cell types (Tabar  & Studer, 2014; Shi et  al., 
2012; Schwartz et  al., 2014; Teng et  al., 2014; Dimos et  al., 
2008; Moretti et  al., 2010), hiPSC in vitro models faithfully 
recapitulate key aspects not only of human development, but 
also of genetic and sporadic disease that would otherwise be 
inaccessible for investigation. Thus, and for the ﬁ rst time in 
regenerative medicine, this technology enables careful tem-
poral interrogation of pathogenic events in a patient-speciﬁ c 
manner using a fully humanised model, which bypasses the 
need for artiﬁ cial overexpression, knockdown or knockout (for 
a schematic, see Figure 1). 
 iPSC technology and its relevance to neurology 
 Neuronal cells have been amongst the earliest cell types to be 
generated via reproducible and eﬃ  cient diﬀ erentiation proto-
cols from hESCs (Reubinoﬀ  et  al., 2001; Zhang et  al., 2001) 
and hiPSCs (Shi et  al., 2012; Chambers et  al., 2009). Protocols 
range from in vitro formation of embryoid bodies exposed to 
retinoic acid in a stage-speciﬁ c manner, co-culture with neural 
inducing feeder cells or direct pharmacological inhibition of 
transforming growth factor (TGF-beta) and bone morphoge-
netic protein (BMP) signalling performed on a monolayer of 
stem cells (dual SMAD inhibition). These approaches can reli-
ably induce neural conversion; the resulting precursors can be 
 ‘ patterned ’ using developmentally rationalised morphogenetic 
cues, and then be terminally diﬀ erentiated into region-speciﬁ c 
neuronal and glial subtypes. 
 Although this technology permits modelling of human de-
velopmental processes and diseases (Lancaster et  al., 2013; 
Marchetto et  al., 2010) in an essentially foetal system (Patani 
et  al., 2012), an ever growing number of studies conﬁ rm that 
mutant hiPSCs derived from patients with inherited disease 
can successfully recapitulate key cellular pathophysiology, 
including those diseases that are adult onset (Dimos et  al., 
2008; Israel et  al., 2012; Koch et  al., 2011; Lee et  al., 2009; 
Sanchez-Danes et  al., 2012; Schondorf et  al., 2014; Woodard 
et  al., 2014). In addition to uncovering cellular and molecu-
lar pathogenesis in inherited and sporadic conditions (Israel 
et  al., 2012; Sanchez-Danes et  al., 2012) hiPSCs can also be 
used successfully to screen for potential novel therapeutics 
(Yang et  al., 2013; Bellin et  al., 2012; Cooper et  al., 2012) or 
to delineate genetic from non-genetic inﬂ uences driving neu-
ronal disease as demonstrated lately for the case of monogenic 
twins discordant in their clinical phenotype with Parkinson ’ s 
disease (PD) (Woodard et  al., 2014). While a comprehensive 
summary of the most important ﬁ ndings from iPSC stud-
ies in the ﬁ eld of neurology is beyond the scope of this ar-
ticle, the interested reader is referred to recent reviews on this 
topic (Xie  & Zhang, 2015; Cao et  al., 2014; Ross  & Akimov, 
2014). Despite this undisputed contribution to understand-
ing development and disease of the human nervous system, 
remaining caveats include possible oncogene reactivation 
via reprogramming procedures, uncontrolled epigenetic and 
genetic modiﬁ cations of generated stem cells and precursors 
from in vitro culture conditions or undiscovered transgene 
integration, low-eﬃ  ciency and non-directed diﬀ erentiation 
that might lead to proliferation and teratoma formation in vivo, 
laborious and expensive culture and experimental settings with 
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DOI: 10.3109/01677063.2015.1053478 iPSC-based models of cerebellar disease 
high intrinsic biological variability. These will require further 
optimisation until this technique can realise its full potential for 
disease modelling, drug discovery and ultimately autologous 
transplantation, although this remains a much longer term aim 
with several unresolved issues to date (Tabar  & Studer, 2014; 
Cyranoski, 2013; Grskovic et  al., 2011; Ausubel et  al., 2011; 
Frantz, 2012; Schwartz et  al., 2012; Kordower et  al., 2008). 
 What distinguishes cerebellar modelling with iPSCs 
from the successful modelling of other subregions of the 
human brain? 
 Modelling cerebellar disease with hiPSC technology has not yet 
become a broadly used routine approach and is reported with 
less frequency compared with other neurological diseases. 
 Progress in modelling cortical, striatal, midbrain, spinal, pe-
ripheral sensory and autonomic nervous system development and 
disease using human pluripotent stem cells is largely attributable 
to the presence of established protocols for directed diﬀ erentiation 
to region speciﬁ c neurons and glia (Shi et  al., 2012; Israel et  al., 
2012; Aubry et  al., 2008; Delli Carri et  al., 2013; Perrier & Pe-
schanski, 2012; Jeon et  al., 2012; Sanchez-Danes et  al., 2012; Per-
rier et  al., 2004; Yan et  al., 2005; Kriks et  al., 2011; Li et  al., 2005, 
2008; Hu & Zhang, 2009; Patani et  al., 2011; Corti et  al., 2012; 
Devlin et  al., 2015; Valensi-Kurtz et  al., 2010; Chambers et  al., 
2012; Lee et  al., 2012; Pomp et  al., 2005). This clearly fosters 
the applicability of hiPSCs in clinical research and further paves 
its way towards translation as reﬂ ected in the number of publica-
tions generated in these respective ﬁ elds. Conversely, modelling 
cerebellar conditions has been hampered by the absence of such 
robust diﬀ erentiation paradigms. Comparing the number of iPSC 
publications investigating neurological non-cerebellar disorders 
to the amount of published work harnessing iPSC technology to 
study cerebellar pathology we currently observe a strong disequi-
librium: (1) the few reports studying cerebellar diseases with iPSC 
technology (Koch et  al., 2011; Eigentler et  al., 2013; Hick et  al., 
2013; Bird et  al., 2014) have derived non-cerebellar cells from pa-
tients with primarily cerebellar phenotypes, (2) no reported study 
thus far has reproduced the single published protocol to specify 
cerebellar-like cells from hiPSCs (Erceg et  al., 2012) available at 
that time. 
 Why is the cerebellum lagging behind? 
 An important contribution to the lack of reliable and eﬃ  cient 
cerebellar diﬀ erentiation protocols might certainly come from 
the rarity of cerebellar diseases. One could argue that simply 
the medical and socio-economic necessity to generate hiPSC 
models of cerebellar disorders is lower and therefore orches-
trated eﬀ orts of developmental biologists have focussed on de-
riving more  ‘ deserving ’ cell types for more common disorders 
such as PD and Alzheimer’s disease (AD). In these disciplines, 
signiﬁ cant progress in directed diﬀ erentiation of disease-rel-
evant neurons has been made (Shi et  al., 2012; Perrier et  al., 
 Figure 1. iPSC technology has already started to foster the study of the human cerebellum and its pathologies in a patient-speciﬁ c way. Overcoming the 
current bottleneck of directed diﬀ erentiation will further facilitate the beneﬁ cial eﬀ ects of this technology on the disorders of the cerebellum.  Cerebellar 
Patient taken from Netter ’ s Concise Neurology, p.85, Elsevier, Inc. (copyright). 
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2004; Yan et  al., 2005; Kriks et  al., 2011). Even though (hered-
itary) degenerative conditions of the cerebellum might be less 
frequent than degenerative conditions of the basal ganglia or 
cortex, the cerebellum is aﬀ ected in a range of common and rare 
conditions, including paraneoplastic cerebellar degeneration, al-
cohol abuse, nutritional deﬁ ciency and rare inherited conditions 
[dominant and recessive spinocerebellar ataxias (SCAs and AR-
CAs)]. Moreover, multiple sclerosis  – the most common cause for 
neurological disability in young people of developed countries  – 
frequently targets the cerebellum, and tumours in the gran-
ule cell (medulloblastomas) represent up to 20 – 40% of brain 
tumours in children and young adults (Arseni  & Ciurea, 1981; 
Salero  & Hatten, 2007). Additionally, cerebellar malforma-
tions (e.g. Dandy – Walker or Arnold – Chiari malformations, 
Joubert syndrome and pontocerebellar hypoplasias) are highly 
disabling both to the aﬀ ected patients and their carers. Cur-
rently, we cannot oﬀ er treatment to prevent ongoing cerebellar 
degeneration, and we will not be able to in the near future, 
unless we understand the molecular and cellular mechanisms 
underlying human cerebellar degeneration more precisely. 
The generation of reliable disease models will be crucial to 
progress in this ﬁ eld. We therefore want to highlight that a 
deeper mechanistic understanding of cerebellar development 
will permit establishment of accurate disease models using 
iPSC technology. Insights into the molecular pathogenesis will 
in turn allow more mechanistically rationalised approaches to 
therapy in this arena. 
 Against this background, it seems plausible that the inher-
ent and notorious developmental complexity of cerebellar cells 
[and especially Purkinje cells (PCs)] and subsequent diﬃ  cul-
ties generating them from human iPSCs have hampered signiﬁ -
cant progress in this ﬁ eld, despite both early (Salero  & Hatten, 
2007; Su et  al., 2006; Muguruma et  al., 2010) and indeed more 
recent developmental breakthroughs (Muguruma et  al., 2015). 
 What has been done to study cerebellar diseases using 
iPSC technology? 
 At the time of writing, the authors are aware of one publication 
using hiPSC-derived long-term self-renewing neuroepithelial-
like stem (lt-NES) cells from patients with SCA3 to study the 
cellular pathology of the most common autosomal-dominant 
degenerative cerebellar disorder (Koch et  al., 2011). Here, the 
inherent diﬃ  culty and the lack of eﬃ  cient in vitro cerebellar 
diﬀ erentiation protocols are circumvented by studying lt-NES 
cells. These cells do express a hindbrain-like transcriptional 
signature with markers usually observed in cells of a ventral 
anterior hindbrain fate (Koch et  al., 2009) which transcription-
ally (and possibly functionally) approximates these cells to the 
cerebellum. Using this model, the authors detected neuron-
speciﬁ c early aberrant protein processing, aggravated by exci-
tation in SCA3 mutant iPSC neurons, thereby breaking a mile-
stone for the ﬁ eld in modelling late-onset cerebellar disease 
in a dish (Koch et  al., 2011). Since then, Friedreich ’ s ataxia, 
the most common autosomal recessive cerebellar disorder with 
additional multisystemic aﬀ ection has been studied through 
various attempts using iPSC technology. Again, investigators 
in these studies utilised non-cerebellar cells to study a cellular 
phenotype (Eigentler et  al., 2013; Hick et  al., 2013; Bird et  al., 
2014; Ku et  al., 2010). None of the above studies reported suc-
cessful utilisation or modiﬁ cation of the  – by that time  – only 
published protocol describing cerebellar-like granule cell dif-
ferentiation from hiPSCs (Erceg et  al., 2012). 
 In order to explain the lack of studies using patient-derived 
iPSCs to generate cerebellar cells and study their pathology we 
need to address the following question: 
 What do we know about the development of 
cerebellar cells that might distinguish them from 
other neuronal cells? 
 Cerebellar development in humans occurs over a prolonged 
time span ranging from the early embryonic period to the ﬁ rst 
postnatal years. It happens in parallel to the development of the 
forebrain, midbrain, spinal cord and their arising substructures, 
but follows its own distinct stereotyped pattern. In summary, 
four basic processes can be delineated: Firstly, the cerebellar 
primordium forms at the midbrain – hindbrain boundary (MHB) 
under close transcriptional inﬂ uence of the isthmic organiser 
(IsO; for more information on this structure, see, Wurst  & Bally-
Cuif, 2001). Subsequently, two diﬀ erent proliferative compart-
ments appear, giving rise to two distinct principal cerebellar cell 
type precursors, which will later migrate and/or diﬀ erentiate to 
form the inhibitory PCs and the excitatory granule cells. In a 
third step, the aforementioned granule precursors migrate tan-
gentially to form the external granule layer (EGL) where sig-
niﬁ cant maturation takes place before they eventually migrate 
radially inwards to their ultimate residence in the internal gran-
ule layer (IGL). Finally, cell maturation and establishment of 
cellular connections characterise the last process giving rise to 
the three-layered cerebellar cortex with its distinct circuitry and 
conserved foliation pattern that organises the cerebellum into 
10 lobules (for more detailed information on cerebellar devel-
opment, please see, Ten Donkelaar  & Lammens, 2009; White 
 & Sillitoe, 2013). It is noteworthy that the cerebellar cortex is 
connected to the remaining neuraxis only via long projecting 
axons arising from PC somata in the central PC layer, which 
exert modulatory inhibitory input to deep cerebellar nuclei 
(DCN). 
 What do we know about the development of 
Purkinje cells that might distinguish them from 
other cerebellar cells? 
 PCs are not only the cerebellum ’ s key eﬀ ectors but they are also 
thought to be primarily aﬀ ected in SCAs (Hekman  & Gomez, 
2015) among other cerebellar conditions. Their pronounced 
sensitivity, morphology, and unique functional circuitry with 
neighbouring cells permits a carefully coordinated output, 
which integrates complex temporal and spatial events at the 
synapse to long-term depression (LTD), or long-term potentia-
tion (LTP) with precision and ﬁ delity (White  & Sillitoe, 2013; 
Schorge et  al., 2010; Buﬀ o  & Rossi, 2013). 
 Their embryonic origin stems from neural progenitor cells 
of the cerebellar ventricular zone (Hoshino, 2006; Hibi  & 
Shimizu, 2012), one of the two germinal layers of the cerebel-
lar primordium. However, it has been intrinsically diﬃ  cult for 
developmental biologists to inﬂ uence PC generation either in 
vivo or in vitro. Although publication bias towards positive 
ﬁ ndings confounds an accurate and comprehensive analysis of 
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past and current attempts at cerebellar neurogenesis, one no-
table recent study demonstrates successful transplantation of 
cerebellar neural stem cells (NSC) into the cerebellum of SCA3 
mutant mice with functional reorganisation (Mendonca et  al., 
2015). This report conﬁ rmed a reduction of mutant ataxin-3 
(ATXN3) inclusions and atrophy within the cellular layers of 
the cerebellum and speciﬁ c preservation of the number of PCs 
post-transplant compared with the non-transplanted mutant 
mice. Importantly this work failed to demonstrate the speciﬁ ca-
tion of PCs from the cerebellar NSC graft in vivo and in vitro, 
thus suggesting an indirect beneﬁ cial eﬀ ect of the graft on PC 
survival and cerebellar integrity. The diﬀ erentiation of TUJ1-
positive neurons, glial ﬁ brillary acidic protein (GFAP)-positive 
astrocytes and neural/glial antigen 2 (NG2)-positive oligoden-
drocytes and their subsequent integration into the cerebellum 
was observed in vivo and in vitro in their mouse model, at the 
expense of PCs. These results seem to be somewhat mirrored 
by the advances in the ﬁ eld of cerebellar cell diﬀ erentiation 
from hiPSCs: whilst there has been no successful report of ma-
ture fully functional PC diﬀ erentiation from hiPSCs or ESCs 
until early 2015 (Muguruma et  al., 2015; Wang et  al., 2015), 
generation of MATH1    cerebellar-like granule cells from hiP-
SCs had been reported years earlier (Erceg et  al., 2012). 
 How can the ﬁ eld move from here? 
 The recent publication of Muguruma et  al. (2015) is a landmark 
study recapitulating key developmental steps in cerebellar 
neurogenesis in order to achieve eﬃ  cient directed diﬀ erentia-
tion of hiPSCs. Brieﬂ y, the authors report regionalising ESC-
derived embryoid bodies to the MHB in vitro and subsequent 
generation of self-organising cerebellar plate neuroepithelium 
(CPNE) that gives rise to mature, fully functional PCs and 
granule cells, as well DCN neurons and various interneurons 
in speciﬁ c co-culture settings. By the precise timing of sequen-
tially administered extrinsic morphogenetic signals [ﬁ broblast 
growth factor2 (FGF2), FGF19 and stromal cell-derived fac-
tor 1 (SDF1)] the team promoted self-formation of continu-
ous CPNE with dorsal-ventral and apical-basal organisation, 
mimicking cerebellar development for the ﬁ rst time in a 
dish. The investigators managed to harness the currently pit-
ted knowledge of developmental cues required for cerebellar 
development to a reductionist 3D culture with external ad-
ministration of three morphogens in a timely deﬁ ned man-
ner only. This proof of principle of cerebellar-like develop-
ment in vitro was conducted on hESCs, although the authors 
also conﬁ rm that the same protocol applied to two hiPSC 
lines yielded similar ﬁ ndings (Muguruma et  al., 2015). This 
study will certainly inspire researchers to reproduce, modify 
(Wang et  al., 2015) and further optimise the protocol (e.g. 
monolayer culture in fully chemically deﬁ ned medium) 
and to use this platform to further investigate human cerebellar 
development and degeneration (see Figure 1). 
 The future of iPSC technology in modelling 
cerebellar diseases 
 If the above-mentioned goal(s) can be met, the future of model-
ling cerebellar diseases with iPSC technology will be bright. We 
are cautiously optimistic that eﬃ  cient and reproducible proto-
cols for the generation of PCs and granule cells from hiPSCs 
will be developed within the coming years using insights from 
developmental biology and also guided by recent breakthroughs 
(Koch et  al., 2011; Muguruma et  al., 2015; Mendonca et  al., 
2015). This will be crucially important to foster this currently 
underrepresented ﬁ eld within hiPSC modelling of neurodegen-
eration. Such advances will permit accurate study of develop-
mental and degenerative processes. Here, having lagged behind 
the main ﬁ eld previously might actually become a strategic 
advantage: important platforms for disease modelling (for re-
cent reviews, please see e.g., Zeng et  al., 2014), drug discovery 
(e.g., Hunsberger et  al., 2015) and evaluation of cell replace-
ment therapies (Kamao et  al., 2014) have been established in 
the meantime successfully for other iPSC-derived cell types, and 
can be adapted to iPSC-derived cerebellar cells by building on 
this important knowledge. Successfully applied, these platforms 
will exert their full potential towards a better understanding of 
cerebellar development, disease pathways and therapeutic av-
 Figure 2. Modelling cerebellar diseases with 
hiPSC technology: past, present and future. We 
think, SCA3 and Friedreich ’ s ataxia (FA), as the 
most common autosomal-dominant and -recessive 
cerebellar degenerative conditions, should be 
remodelled using PCs diﬀ erentiated from patient-
derived iPSCs once possible. Furthermore, 
preferential choice should target cerebellar diseases 
due to genetic defects in pathophysiologically widely 
linked genes, e.g. SCA15 (Schorge et  al., 2010), and 
employ suitable cellular readouts with a focus on 
electrophysiology and live-cell imaging to widen our 
knowledge about cerebellar diseases as  ‘ impaired 
network and impaired plasticity ’ disorders. 
DOI: 10.3109/01677063.2015.1053478 iPSC-based models of cerebellar disease 99
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enues in cerebellar disease. We depict this in a time bar summa-
rising past eﬀ orts (blue and black font) with future predictions 
(red font) which may be of special interest to model genetic cer-
ebellar diseases with iPSC technology (Figure 2). Furthermore, 
eﬀ orts in establishing accurate cerebellar in vitro disease models 
will  – as has happened in other ﬁ elds already (Soldner et  al., 
2011)  – be complemented by the generation of isogenic hiPSC 
lines via modern genomic editing techniques (Hockemeyer 
et  al., 2009, 2011). Such approaches allow introducing or  ‘ cor-
recting ’ diﬀ erent mutations that solely aﬀ ect cerebellar integrity 
against an identical genetic background to precisely disentangle 
disease-causing mechanisms from background genomic varia-
tion between diﬀ erent lines. Finally, the gathered knowledge and 
progress towards eﬃ  cient cerebellar diﬀ erentiation protocols 
will impact on direct lineage reprogramming eﬀ orts (for recent 
reviews, please see, Ladewig et  al., 2013; Vierbuchen  & Wernig, 
2012). 
 In summary, the cerebellum currently fails to obtain com-
parable experimental recognition as other neuraxial regions 
largely due to a poor translation of its underlying developmental 
biology into directed diﬀ erentiation strategies. Noting recent 
breakthroughs in the directed diﬀ erentiation of human pluripo-
tent stem cells into cerebellar derivatives, we predict that this 
hitherto relatively understudied region of the neuraxis can now 
begin to receive the experimental attention it deserves. This in 
turn may illuminate the precise mechanisms of cerebellar devel-
opment and degeneration, thus informing therapeutic strategy. 
 Acknowledgements 
 S.W. is supported by a BRT studentship (Brain Research 
Trust). R.P. is a Wellcome Trust Intermediate Clinical Fellow 
(101149/Z/13/Z) and an Anne Rowling Fellow in Regenerative 
Neurology. 
 Declaration of interest 
 The authors report no declarations of interest. The authors 
alone are responsible for the content and writing of the paper. 
 References 
 Anand ,  B. K. ,  Malhotra ,  C. L. ,  Singh ,  B .,  &  Dua ,  S .  (1959) .  Cerebellar 
projections to limbic system .  J Neurophysiol ,  22 ,  451 – 457 . 
 Arseni ,  C .,  &  Ciurea ,  A. V.  (1981) .  Statistical survey of 276 cases of 
medulloblastoma (1935 – 1978) .  Acta Neurochir ,  57 ,  159 – 162 . 
 Aubry ,  L .,  Bugi ,  A .,  Lefort ,  N .,  Rousseau ,  F .,  Peschanski ,  M .,  &  Perrier , 
 A. L.  (2008) .  Striatal progenitors derived from human ES cells mature 
into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats . 
 Proc Natl Acad Sci U S A ,  105 ,  16707 – 16712 . 
 Ausubel ,  L. J. ,  Lopez ,  P. M. ,  &  Couture ,  L. A.  (2011) .  GMP scale-up 
and banking of pluripotent stem cells for cellular therapy applications . 
 Methods Mol Biol ,  767 ,  147 – 159 . 
 Azevedo ,  F. A. ,  Carvalho ,  L. R. ,  Grinberg ,  L. T. ,  Farfel ,  J. M. ,  Ferretti , 
 R. E. ,  Leite ,  R. E. ,  et  al .  (2009) .  Equal numbers of neuronal and 
nonneuronal cells make the human brain an isometrically scaled-up 
primate brain .  J Comp Neurol ,  513 ,  532 – 541 . 
 Bellin ,  M .,  Marchetto ,  M. C. ,  Gage ,  F. H. ,  &  Mummery ,  C. L.  (2012) . 
 Induced pluripotent stem cells: The new patient?  Nat Rev Mol Cell 
Biol ,  13 ,  713 – 726 . 
 Bird ,  M. J. ,  Needham ,  K .,  Frazier ,  A. E. ,  van Rooijen ,  J .,  Leung ,  J ., 
 Hough ,  S .,  et  al .  (2014) .  Functional characterization of Friedreich 
ataxia iPS-derived neuronal progenitors and their integration in the 
adult brain .  PLoS one ,  9 ,  e101718 . 
 Buﬀ o ,  A .,  &  Rossi ,  F .  (2013) .  Origin, lineage and function of cerebellar 
glia .  Prog Neurobiol ,  109 ,  42 – 63 . 
 Cao ,  L .,  Tan ,  L .,  Jiang ,  T .,  Zhu ,  X. C. ,  &  Yu ,  J. T.  (2014) .  Induced 
pluripotent stem cells for disease modeling and drug discovery in 
neurodegenerative diseases .  Mol Neurobiol ,  Epub ahead of print .
 Chambers ,  S. M. ,  Fasano ,  C. A. ,  Papapetrou ,  E. P. ,  Tomishima ,  M ., 
 Sadelain ,  M .,  &  Studer ,  L .  (2009) .  Highly eﬃ  cient neural conversion 
of human ES and iPS cells by dual inhibition of SMAD signaling . 
 Nat Biotechnol ,  27 ,  275 – 280 . 
 Chambers ,  S. M. ,  Qi ,  Y .,  Mica ,  Y .,  Lee ,  G .,  Zhang ,  X. J. ,  Niu ,  L ., 
 et  al .  (2012) .  Combined small-molecule inhibition accelerates 
developmental timing and converts human pluripotent stem cells into 
nociceptors .  Nat Biotechnol ,  30 ,  715 – 720 . 
 Cooper ,  O .,  Seo ,  H .,  Andrabi ,  S .,  Guardia-Laguarta ,  C .,  Graziotto ,  J ., 
 Sundberg ,  M .,  et  al .  (2012) .  Pharmacological rescue of mitochondrial 
deﬁ cits in iPSC-derived neural cells from patients with familial 
Parkinson ’ s disease .  Sci Transl Med ,  4 ,  141ra90 . 
 Corti ,  S .,  Nizzardo ,  M .,  Simone ,  C .,  Falcone ,  M .,  Nardini ,  M .,  Ronchi , 
 D .,  et  al .  (2012) .  Genetic correction of human induced pluripotent 
stem cells from patients with spinal muscular atrophy .  Sci Transl Med , 
 4 ,  165ra2 . 
 Cyranoski ,  D .  (2013) .  Stem cells cruise to clinic .  Nature ,  494 ,  413 . 
 De Zeeuw ,  C. I. ,  &  Berrebi ,  A. S.  (1995) .  Postsynaptic targets of Purkinje 
cell terminals in the cerebellar and vestibular nuclei of the rat .  Eur J 
Neurosci ,  7 ,  2322 – 2333 . 
 Delli Carri ,  A .,  Onorati ,  M .,  Lelos ,  M. J. ,  Castiglioni ,  V .,  Faedo ,  A ., 
 Menon ,  R .,  et  al .  (2013) .  Developmentally coordinated extrinsic 
signals drive human pluripotent stem cell diﬀ erentiation toward 
authentic DARPP-32    medium-sized spiny neurons .  Development , 
 140 ,  301 – 312 . 
 Devlin ,  A. C. ,  Burr ,  K .,  Borooah ,  S .,  Foster ,  J. D. ,  Cleary ,  E. M. ,  Geti ,  I ., 
 et  al .  (2015) .  Human iPSC-derived motoneurons harbouring TARDBP 
or C9ORF72 ALS mutations are dysfunctional despite maintaining 
viability .  Nat commun ,  6 ,  5999 . 
 Dimos ,  J. T. ,  Rodolfa ,  K. T. ,  Niakan ,  K. K. ,  Weisenthal ,  L. M. , 
 Mitsumoto ,  H .,  Chung ,  W .,  et  al .  (2008) .  Induced pluripotent stem 
cells generated from patients with ALS can be diﬀ erentiated into 
motor neurons .  Science ,  321 ,  1218 – 1221 . 
 Efthymiou ,  A .,  Shaltouki ,  A .,  Steiner ,  J. P. ,  Jha ,  B .,  Heman-Ackah ,  S. 
M. ,  Swistowski ,  A .,  et  al .  (2014) .  Functional screening assays with 
neurons generated from pluripotent stem cell-derived neural stem cells . 
 J Biomol Screen ,  19 ,  32 – 43 . 
 Eigentler ,  A .,  Boesch ,  S .,  Schneider ,  R .,  Dechant ,  G .,  &  Nat ,  R .  (2013) . 
 Induced pluripotent stem cells from friedreich ataxia patients fail to 
upregulate frataxin during in vitro diﬀ erentiation to peripheral sensory 
neurons .  Stem Cells Dev ,  22 ,  3271 – 3282 . 
 Erceg ,  S .,  Lukovic ,  D .,  Moreno-Manzano ,  V .,  Stojkovic ,  M .,  & 
 Bhattacharya ,  S. S.  (2012) .  Derivation of cerebellar neurons from 
human pluripotent stem cells .  Curr Protoc Stem Cell Biol ,  Chapter 1 , 
 Unit 1H 5 . 
 Frantz ,  S .  (2012) .  Embryonic stem cell pioneer Geron exits ﬁ eld, cuts 
losses .  Nat Biotechnol ,  30 ,  12 – 13 . 
 Glickstein ,  M .,  Strata ,  P .,  &  Voogd ,  J .  (2009) .  Cerebellum: History . 
 Neuroscience ,  162 ,  549 – 559 . 
 Grskovic ,  M .,  Javaherian ,  A .,  Strulovici ,  B .,  &  Daley ,  G. Q.  (2011) . 
 Induced pluripotent stem cells – opportunities for disease modelling and 
drug discovery .  Nat Rev Drug Discov ,  10 ,  915 – 929 . 
 Hekman ,  K. E. ,  &  Gomez ,  C. M.  (2015) .  The autosomal dominant 
spinocerebellar ataxias: Emerging mechanistic themes suggest pervasive 
Purkinje cell vulnerability .  J Neurol Neurosurg Psychiatry ,  86 ,  554 – 61 . 
 Hibi ,  M .,  &  Shimizu ,  T .  (2012) .  Development of the cerebellum and 
cerebellar neural circuits .  Dev Neurobiol ,  72 ,  282 – 301 . 
 Hick ,  A .,  Wattenhofer-Donze ,  M .,  Chintawar ,  S .,  Tropel ,  P .,  Simard ,  J. P. , 
 Vaucamps ,  N .,  et  al .  (2013) .  Neurons and cardiomyocytes derived from 
induced pluripotent stem cells as a model for mitochondrial defects in 
Friedreich ’ s ataxia .  Dis Model Mech ,  6 ,  608 – 621 . 
 Hockemeyer ,  D .,  Soldner ,  F .,  Beard ,  C .,  Gao ,  Q .,  Mitalipova ,  M .,  DeKelver , 
 R. C. ,  et  al .  (2009) .  Eﬃ  cient targeting of expressed and silent genes in 
human ESCs and iPSCs using zinc-ﬁ nger nucleases .  Nat Biotechnol , 
 27 ,  851 – 857 . 
 Hockemeyer ,  D .,  Wang ,  H .,  Kiani ,  S .,  Lai ,  C. S. ,  Gao ,  Q .,  Cassady ,  J. 
P. ,  et  al .  (2011) .  Genetic engineering of human pluripotent cells using 
TALE nucleases .  Nat Biotechnol ,  29 ,  731 – 734 . 
 Hoshino ,  M .  (2006) .  Molecular machinery governing GABAergic neuron 
speciﬁ cation in the cerebellum .  Cerebellum ,  5 ,  193 – 198 . 
 S. Wiethoﬀ  et al. J Neurogenetics, 2015; 29(2-3): 95–102100
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 C
oll
eg
e L
on
do
n]
 at
 05
:05
 19
 N
ov
em
be
r 2
01
5 
 Hou ,  P .,  Li ,  Y .,  Zhang ,  X .,  Liu ,  C .,  Guan ,  J .,  Li ,  H .,  et  al .  (2013) . 
 Pluripotent stem cells induced from mouse somatic cells by small-
molecule compounds .  Science ,  341 ,  651 – 654 . 
 Hu ,  B. Y. ,  &  Zhang ,  S. C.  (2009) .  Diﬀ erentiation of spinal motor neurons 
from pluripotent human stem cells .  Nat Protoc ,  4 ,  1295 – 1304 . 
 Hunsberger ,  J .,  Efthymiou ,  A. G. ,  Malik ,  N .,  Behl ,  M .,  Mead ,  I. L. ,  Zeng , 
 X .,  et  al .  (2015) .  Induced pluripotent stem cell models to enable in 
vitro models for screening in the CNS .  Stem Cells Dev, Epub ahead 
of print .
 Israel ,  M. A. ,  Yuan ,  S. H. ,  Bardy ,  C .,  Reyna ,  S. M. ,  Mu ,  Y .,  Herrera ,  C ., 
 et  al .  (2012) .  Probing sporadic and familial Alzheimer ’ s disease using 
induced pluripotent stem cells .  Nature ,  482 ,  216 – 220 . 
 Ito ,  M .  (1984) .  The modiﬁ able neuronal network of the cerebellum .  Jpn J 
Physiol ,  34 ,  781 – 792 . 
 Jeon ,  I .,  Lee ,  N .,  Li ,  J. Y. ,  Park ,  I. H. ,  Park ,  K. S. ,  Moon ,  J .,  et  al .  (2012) . 
 Neuronal properties, in vivo eﬀ ects, and pathology of a Huntington ’ s 
disease patient-derived induced pluripotent stem cells .  Stem Cells ,  30 , 
 2054 – 2062 . 
 Jiang ,  J .,  Lv ,  W .,  Ye ,  X .,  Wang ,  L .,  Zhang ,  M .,  Yang ,  H .,  et  al .  (2013) . 
 Zscan4 promotes genomic stability during reprogramming and 
dramatically improves the quality of iPS cells as demonstrated by 
tetraploid complementation .  Cell Res ,  23 ,  92 – 106 . 
 Kamao ,  H .,  Mandai ,  M .,  Okamoto ,  S .,  Sakai ,  N .,  Suga ,  A .,  Sugita ,  S ., 
 et  al .  (2014) .  Characterization of human induced pluripotent stem 
cell-derived retinal pigment epithelium cell sheets aiming for clinical 
application .  Stem Cell Rep ,  2 ,  205 – 218 . 
 Koch ,  P .,  Breuer ,  P .,  Peitz ,  M .,  Jungverdorben ,  J .,  Kesavan ,  J .,  Poppe ,  D ., 
 et  al .  (2011) .  Excitation-induced ataxin-3 aggregation in neurons from 
patients with Machado-Joseph disease .  Nature ,  480 ,  543 – 546 . 
 Koch ,  P .,  Opitz ,  T .,  Steinbeck ,  J. A. ,  Ladewig ,  J .,  &  Brustle ,  O .  (2009) . 
 A rosette-type, self-renewing human ES cell-derived neural stem cell 
with potential for in vitro instruction and synaptic integration .  Proc 
Natl Acad Sci U S A ,  106 ,  3225 – 3230 . 
 Kordower ,  J. H. ,  Chu ,  Y .,  Hauser ,  R. A. ,  Freeman ,  T. B. ,  &  Olanow ,  C. 
W.  (2008) .  Lewy body-like pathology in long-term embryonic nigral 
transplants in Parkinson ’ s disease .  Nat Med ,  14 ,  504 – 506 . 
 Kriks ,  S .,  Shim ,  J. W. ,  Piao ,  J .,  Ganat ,  Y. M. ,  Wakeman ,  D. R. ,  Xie , 
 Z .,  et  al .  (2011) .  Dopamine neurons derived from human ES cells 
eﬃ  ciently engraft in animal models of Parkinson ’ s disease .  Nature , 
 480 ,  547 – 551 . 
 Ku ,  S .,  Soragni ,  E .,  Campau ,  E .,  Thomas ,  E. A. ,  Altun ,  G .,  Laurent ,  L. C. , 
 et  al .  (2010) .  Friedreich ’ s ataxia induced pluripotent stem cells model 
intergenerational GAATTC triplet repeat instability .  Cell Stem Cell ,  7 , 
 631 – 637 . 
 Ladewig ,  J .,  Koch ,  P .,  &  Brustle ,  O .  (2013) .  Leveling Waddington: The 
emergence of direct programming and the loss of cell fate hierarchies . 
 Nat Rev Mol Cell Biol ,  14 ,  225 – 236 . 
 Lancaster ,  M. A. ,  Renner ,  M .,  Martin ,  C. A. ,  Wenzel ,  D .,  Bicknell ,  L. S. , 
 Hurles ,  M. E. ,  et  al .  (2013) .  Cerebral organoids model human brain 
development and microcephaly .  Nature ,  501 ,  373 – 379 . 
 Lee ,  G .,  Papapetrou ,  E. P. ,  Kim ,  H .,  Chambers ,  S. M. ,  Tomishima ,  M. 
J. ,  Fasano ,  C. A. ,  et  al .  (2009) .  Modelling pathogenesis and treatment 
of familial dysautonomia using patient-speciﬁ c iPSCs .  Nature ,  461 , 
 402 – 406 . 
 Lee ,  K. S. ,  Zhou ,  W .,  Scott-McKean ,  J. J. ,  Emmerling ,  K. L. ,  Cai ,  G. 
Y. ,  Krah ,  D. L. ,  et  al .  (2012) .  Human sensory neurons derived from 
induced pluripotent stem cells support varicella-zoster virus infection . 
 PLoS one ,  7 ,  e53010 . 
 Leiner ,  H. C.  (2010) .  Solving the mystery of the human cerebellum . 
 Neuropsychology Rev ,  20 ,  229 – 235 . 
 Li ,  X. J. ,  Du ,  Z. W. ,  Zarnowska ,  E. D. ,  Pankratz ,  M .,  Hansen ,  L. O. , 
 Pearce ,  R. A. ,  et  al .  (2005) .  Speciﬁ cation of motoneurons from human 
embryonic stem cells .  Nat Biotechnol ,  23 ,  215 – 221 . 
 Li ,  X. J. ,  Hu ,  B. Y. ,  Jones ,  S. A. ,  Zhang ,  Y. S. ,  Lavaute ,  T .,  Du ,  Z. W. , 
 et  al .  (2008) .  Directed diﬀ erentiation of ventral spinal progenitors and 
motor neurons from human embryonic stem cells by small molecules . 
 Stem Cells ,  26 ,  886 – 893 . 
 Malik ,  N .,  Efthymiou ,  A. G. ,  Mather ,  K .,  Chester ,  N .,  Wang ,  X .,  Nath ,  A ., 
 et  al .  (2014) .  Compounds with species and cell type speciﬁ c toxicity 
identiﬁ ed in a 2000 compound drug screen of neural stem cells and rat 
mixed cortical neurons .  Neurotoxicology ,  45 ,  192 – 200 . 
 Manto ,  M .  (2008) .  The cerebellum, cerebellar disorders, and cerebellar 
research – two centuries of discoveries .  Cerebellum ,  7 ,  505 – 516 . 
 Marchetto ,  M. C. ,  Carromeu ,  C .,  Acab ,  A .,  Yu ,  D .,  Yeo ,  G. W. ,  Mu , 
 Y .,  et  al .  (2010) .  A model for neural development and treatment of 
Rett syndrome using human induced pluripotent stem cells .  Cell ,  143 , 
 527 – 539 . 
 Mendonca ,  L. S. ,  Nobrega ,  C .,  Hirai ,  H .,  Kaspar ,  B. K. ,  Pereira de 
Almeida ,  L .  (2015) .  Transplantation of cerebellar neural stem cells 
improves motor coordination and neuropathology in Machado-Joseph 
disease mice .  Brain ,  138 ,  320 – 335 . 
 Moretti ,  A .,  Bellin ,  M .,  Welling ,  A .,  Jung ,  C. B. ,  Lam ,  J. T. ,  Bott-Flugel , 
 L .,  et  al .  (2010) .  Patient-speciﬁ c induced pluripotent stem-cell models 
for long-QT syndrome .  N Engl J Med ,  363 ,  1397 – 1409 . 
 Muguruma ,  K .,  Nishiyama ,  A .,  Kawakami ,  H .,  Hashimoto ,  K .,  &  
 Sasai ,  Y .  (2015) .  Self-organization of polarized cerebellar tissue in 3D 
culture of human pluripotent stem cells .  Cell Rep ,  10 ,  537 – 50 . 
 Muguruma ,  K .,  Nishiyama ,  A .,  Ono ,  Y .,  Miyawaki ,  H .,  Mizuhara , 
 E .,  Hori ,  S .,  et  al .  (2010) .  Ontogeny-recapitulating generation and 
tissue integration of ES cell-derived Purkinje cells .  Nat Neurosci ,  13 , 
 1171 – 1180 . 
 Okita ,  K .,  Matsumura ,  Y .,  Sato ,  Y .,  Okada ,  A .,  Morizane ,  A .,  Okamoto , 
 S .,  et  al .  (2011) .  A more eﬃ  cient method to generate integration-free 
human iPS cells .  Nat Methods ,  8 ,  409 – 412 . 
 Patani ,  R .,  Hollins ,  A. J. ,  Wishart ,  T. M. ,  Puddifoot ,  C. A. ,  Alvarez ,  S ., 
 de Lera ,  A. R. ,  et  al .  (2011) .  Retinoid-independent motor neurogenesis 
from human embryonic stem cells reveals a medial columnar ground 
state .  Nature commun ,  2 ,  214 . 
 Patani ,  R .,  Lewis ,  P. A. ,  Trabzuni ,  D .,  Puddifoot ,  C. A. ,  Wyllie ,  D. J. , 
 Walker ,  R .,  et  al .  (2012) .  Investigating the utility of human embryonic 
stem cell-derived neurons to model ageing and neurodegenerative 
disease using whole-genome gene expression and splicing analysis .  J 
Neurochem ,  122 ,  738 – 751 . 
 Perrier ,  A. L. ,  Tabar ,  V .,  Barberi ,  T .,  Rubio ,  M. E. ,  Bruses ,  J ., 
 Topf ,  N .,  et  al .  (2004) .  Derivation of midbrain dopamine neurons 
from human embryonic stem cells .  Proc Natl Acad Sci U S A ,  101 , 
 12543 – 12548 . 
 Perrier ,  A .,  &  Peschanski ,  M .  (2012) .  How can human pluripotent stem 
cells help decipher and cure Huntington ’ s disease?  Cell Stem Cell ,  11 , 
 153 – 161 . 
 Pomp ,  O .,  Brokhman ,  I .,  Ben-Dor ,  I .,  Reubinoﬀ  ,  B .,  &  Goldstein ,  R. S. 
 (2005) .  Generation of peripheral sensory and sympathetic neurons and 
neural crest cells from human embryonic stem cells .  Stem Cells ,  23 , 
 923 – 930 . 
 Reubinoﬀ  ,  B. E. ,  Itsykson ,  P .,  Turetsky ,  T .,  Pera ,  M. F. ,  Reinhartz ,  E ., 
 Itzik ,  A .,  et  al .  (2001) .  Neural progenitors from human embryonic stem 
cells .  Nat Biotechnol ,  19 ,  1134 – 1140 . 
 Ross ,  C. A. ,  &  Akimov ,  S. S.  (2014) .  Human-induced pluripotent stem 
cells: Potential for neurodegenerative diseases .  Hum Mol Genet ,  23 , 
 R17 – 26 . 
 Ruigrok ,  T. J.  (2011) .  Ins and outs of cerebellar modules .  Cerebellum , 
 10 ,  464 – 474 . 
 Salero ,  E .,  &  Hatten ,  M. E.  (2007) .  Diﬀ erentiation of ES cells into 
cerebellar neurons .  Proc Natl Acad Sci U S A ,  104 ,  2997 – 3002 . 
 Sanchez-Danes ,  A .,  Richaud-Patin ,  Y .,  Carballo-Carbajal ,  I ., 
 Jimenez-Delgado ,  S .,  Caig ,  C .,  Mora ,  S .,  et  al .  (2012) .  Disease-speciﬁ c 
phenotypes in dopamine neurons from human iPS-based models 
of genetic and sporadic Parkinson ’ s disease .  EMBO Mol Med ,  4 , 
 380 – 395 . 
 Schlaeger ,  T. M. ,  Daheron ,  L .,  Brickler ,  T. R. ,  Entwisle ,  S .,  Chan , 
 K .,  Cianci ,  A .,  et  al .  (2015) .  A comparison of non-integrating 
reprogramming methods .  Nat Biotechnol ,  33 ,  58 – 63 . 
 Schmahmann ,  J. D.  (1997) .  Rediscovery of an early concept .  Int Rev 
Neurobiol ,  41 ,  3 – 27 . 
 Schondorf ,  D. C. ,  Aureli ,  M .,  McAllister ,  F. E. ,  Hindley ,  C. J. ,  Mayer ,  F ., 
 Schmid ,  B .,  et  al .  (2014) .  iPSC-derived neurons from GBA1-associated 
Parkinson ’ s disease patients show autophagic defects and impaired 
calcium homeostasis .  Nat Commun ,  5 ,  4028 . 
 Schorge ,  S .,  van de Leemput ,  J .,  Singleton ,  A .,  Houlden ,  H .,  &  Hardy ,  J . 
 (2010) .  Human ataxias: A genetic dissection of inositol triphosphate 
receptor (ITPR1)-dependent signaling .  Trends Neurosci ,  33 , 
 211 – 219 . 
 Schwartz ,  R. E. ,  Fleming ,  H. E. ,  Khetani ,  S. R. ,  &  Bhatia ,  S. N.  (2014) .  Pluripotent 
stem cell-derived hepatocyte-like cells .  Biotechnol Adv ,  32 ,  504 – 513 . 
 Schwartz ,  S. D. ,  Hubschman ,  J. P. ,  Heilwell ,  G .,  Franco-Cardenas ,  V ., 
 Pan ,  C. K. ,  Ostrick ,  R. M. ,  et  al .  (2012) .  Embryonic stem cell trials for 
macular degeneration: a preliminary report .  Lancet ,  379 ,  713 – 720 . 
 Shi ,  Y .,  Kirwan ,  P .,  &  Livesey ,  F. J.  (2012) .  Directed diﬀ erentiation of 
human pluripotent stem cells to cerebral cortex neurons and neural 
networks .  Nat Protoc ,  7 ,  1836 – 1846 . 
DOI: 10.3109/01677063.2015.1053478 iPSC-based models of cerebellar disease 101
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 C
oll
eg
e L
on
do
n]
 at
 05
:05
 19
 N
ov
em
be
r 2
01
5 
 Soldner ,  F .,  Laganiere ,  J .,  Cheng ,  A. W. ,  Hockemeyer ,  D .,  Gao ,  Q ., 
 Alagappan ,  R .,  et  al .  (2011) .  Generation of isogenic pluripotent stem 
cells diﬀ ering exclusively at two early onset Parkinson point mutations . 
 Cell ,  146 ,  318 – 331 . 
 Strata ,  P .  (2015) .  The emotional cerebellum .  Cerebellum ,  Epub ahead of 
print . 
 Strick ,  P. L. ,  Dum ,  R. P. ,  &  Fiez ,  J. A.  (2009) .  Cerebellum and nonmotor 
function .  Annu Rev Neurosci ,  32 ,  413 – 434 . 
 Su ,  H. L. ,  Muguruma ,  K .,  Matsuo-Takasaki ,  M .,  Kengaku ,  M ., 
 Watanabe ,  K .,  &  Sasai ,  Y .  (2006) .  Generation of cerebellar neuron 
precursors from embryonic stem cells .  Dev Biol ,  290 ,  287 – 296 . 
 Tabar ,  V .,  &  Studer ,  L .  (2014) .  Pluripotent stem cells in regenerative 
medicine: Challenges and recent progress .  Nat Rev Genet ,  15 , 
 82 – 92 . 
 Takahashi ,  K .,  Tanabe ,  K .,  Ohnuki ,  M .,  Narita ,  M .,  Ichisaka ,  T ., 
 Tomoda ,  K .,  et  al .  (2007) .  Induction of pluripotent stem cells from 
adult human ﬁ broblasts by deﬁ ned factors .  Cell ,  131 ,  861 – 872 . 
 Ten Donkelaar ,  H. J. ,  &  Lammens ,  M .  (2009) .  Development of the 
human cerebellum and its disorders .  Clin Perinatol ,  36 ,  513 – 530 . 
 Teng ,  S .,  Liu ,  C .,  Krettek ,  C .,  &  Jagodzinski ,  M .  (2014) .  The application 
of induced pluripotent stem cells for bone regeneration: Current 
progress and prospects .  Tissue Eng Part B Rev ,  20 ,  328 – 339 . 
 Timmann ,  D .  (2012) . [Contribution of the cerebellum to cognition] . 
 Fortschr Neurol Psychiatr ,  80 ,  44 – 52 . 
 Valensi-Kurtz ,  M .,  Leﬂ er ,  S .,  Cohen ,  M. A. ,  Aharonowiz ,  M .,  Cohen-Kupiec , 
 R .,  Sheinin ,  A .,  et  al .  (2010) .  Enriched population of PNS neurons derived 
from human embryonic stem cells as a platform for studying peripheral 
neuropathies .  PLoS One ,  5 ,  e9290 . 
 Vierbuchen ,  T. ,  &  Wernig ,  M .  (2012) .  Molecular roadblocks for cellular 
reprogramming .  Mol Cell ,  47 ,  827 – 838 . 
 Voogd ,  J .  (2014) .  What we do not know about cerebellar systems 
neuroscience .  Front Syst Neurosci ,  8 ,  227 . 
 Voogd ,  J .,  Gerrits ,  N. M. ,  &  Ruigrok ,  T. J.  (1996) .  Organization of the 
vestibulocerebellum .  Ann N Y Acad Sci ,  781 ,  553 – 579 . 
 Wang ,  S .,  Wang ,  B .,  Pan ,  N .,  Fu ,  L .,  Wang ,  C .,  Song ,  G .,  et  al .  (2015) . 
 Diﬀ erentiation of human induced pluripotent stem cells to mature 
functional Purkinje neurons .  Sci Rep ,  5 ,  9232 . 
 Warren ,  L .,  Manos ,  P. D. ,  Ahfeldt ,  T .,  Loh ,  Y. H. ,  Li ,  H .,  Lau ,  F .,  et  al . 
 (2010) .  Highly eﬃ  cient reprogramming to pluripotency and directed 
diﬀ erentiation of human cells with synthetic modiﬁ ed mRNA .  Cell 
Stem Cell ,  7 ,  618 – 630 . 
 White ,  J. J. ,  &  Sillitoe ,  R. V.  (2013) .  Development of the cerebellum: 
from gene expression patterns to circuit maps .  Wiley Interdiscip Rev 
Dev Biol ,  2 ,  149 – 164 . 
 Woodard ,  C. M. ,  Campos ,  B. A. ,  Kuo ,  S. H. ,  Nirenberg ,  M. J. ,  Nestor ,  M. 
W. ,  Zimmer ,  M .,  et  al .  (2014) .  iPSC-derived dopamine neurons reveal 
diﬀ erences between monozygotic twins discordant for Parkinson ’ s 
disease .  Cell Rep ,  9 ,  1173 – 1182 . 
 Wurst ,  W .,  Bally-Cuif ,  L .  (2001) .  Neural plate patterning: Upstream 
and downstream of the isthmic organizer .  Nat Rev Neurosci ,  2 ,  99 –
 108 . 
 Xie ,  Y. Z. ,  &  Zhang ,  R. X.  (2015) .  Neurodegenerative diseases in a dish: 
The promise of iPSC technology in disease modeling and therapeutic 
discovery .  Neurol Sci ,  36 ,  21 – 27 . 
 Yamanaka ,  S .,  &  Blau ,  H. M.  (2010) .  Nuclear reprogramming to a 
pluripotent state by three approaches .  Nature ,  465 ,  704 – 712 . 
 Yan ,  Y .,  Yang ,  D .,  Zarnowska ,  E. D. ,  Du ,  Z .,  Werbel ,  B .,  Valliere ,  C ., 
 et  al .  (2005) .  Directed diﬀ erentiation of dopaminergic neuronal 
subtypes from human embryonic stem cells .  Stem Cells ,  23 ,  781 –
 790 . 
 Yang ,  Y. M. ,  Gupta ,  S. K. ,  Kim ,  K. J. ,  Powers ,  B. E. ,  Cerqueira ,  A ., 
 Wainger ,  B. J. ,  et  al .  (2013) .  A small molecule screen in stem-cell-
derived motor neurons identiﬁ es a kinase inhibitor as a candidate 
therapeutic for ALS .  Cell Stem Cell ,  12 ,  713 – 726 . 
 Yu ,  J .,  Hu ,  K .,  Smuga-Otto ,  K .,  Tian ,  S .,  Stewart ,  R .,  Slukvin ,  I. I. , 
 Thomson ,  J. A. .  (2009) .  Human induced pluripotent stem cells free of 
vector and transgene sequences .  Science ,  324 ,  797 – 801 . 
 Zeng ,  X .,  Hunsberger ,  J. G. ,  Simeonov ,  A .,  Malik ,  N .,  Pei ,  Y .,  & 
 Rao ,  M .  (2014) .  Concise review: modeling central nervous system 
diseases using induced pluripotent stem cells .  Stem Cells Transl Med , 
 3 ,  1418 – 1428 . 
 Zhang ,  S. C. ,  Wernig ,  M .,  Duncan ,  I. D. ,  Brustle ,  O .,  &  Thomson ,  J. A. 
 (2001) .  In vitro differentiation of transplantable neural precursors 
from human embryonic stem cells .  Nat Biotechnol ,  19 ,  1129 – 1133 . 
 S. Wiethoﬀ  et al. J Neurogenetics, 2015; 29(2-3): 95–102102
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 C
oll
eg
e L
on
do
n]
 at
 05
:05
 19
 N
ov
em
be
r 2
01
5 
